Cargando…
The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process
The adenovirus vector vaccines induce humoral and cellular immune responses and have been used to develop vaccines for effective prevention of life-threating viruses, such as Ebola and Coronaviruses. High demand of vaccines worldwide requires optimization of the production process. Perfusion process...
Autores principales: | Nie, Jianqi, Sun, Yang, Feng, Kai, Huang, Lingling, Li, Ye, Bai, Zhonghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863426/ https://www.ncbi.nlm.nih.gov/pubmed/35216843 http://dx.doi.org/10.1016/j.vaccine.2022.02.024 |
Ejemplares similares
-
Development of a perfusion process for serum-free adenovirus vector herpes zoster vaccine production
por: Sun, Yang, et al.
Publicado: (2022) -
Optimization of an adenovirus-vectored zoster vaccine production process with chemically defined medium and a perfusion system
por: Nie, Jianqi, et al.
Publicado: (2022) -
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023) -
Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine
por: Ilyas, Sahrish, et al.
Publicado: (2020) -
Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022)